Staff Spotlight: Mary Ellis Bogden, Associate Director, Regulatory Writing Services

Mary Ellis Bogden joined Med Communications earlier this year as Associate Director, Regulatory Writing Services. When it comes to navigating complex regulatory pathways and bringing therapies closer to patients, few professionals offer the depth of experience and strategic insight that she brings to every project. Mary has been instrumental in delivering successful global submissions for pharmaceutical and biotech organizations for over 30 years, leveraging senior leadership and director-level expertise in medical and regulatory writing, Chemistry, Manufacturing & Controls (CMC) regulatory affairs, and pharmaceutical development.

She is recognized for building high-performing teams, fostering strong client partnerships, and delivering strategic regulatory solutions that help organizations achieve regulatory milestones. Her expertise includes CMC regulatory writing and submission planning and strategy. Throughout her career, Mary has served as lead author and strategic CMC regulatory partner for a broad range of global investigational and marketing applications, including INDs, IMPDs, and CTAs supporting clinical development programs, as well as NDAs, BLAs, MAAs, ANDAs, and DMFs supporting product approvals and commercialization worldwide.

She consistently delivers high-impact documents helping pharmaceutical and biotechnology companies advance products from early development through market authorization.

We are proud to have Mary on the Med Communications team, helping clients navigate regulatory complexity with confidence, clarity, and strategic expertise. Feel free to connect with Mary on LinkedIn, or contact her at 877.477.0977 or https://medcommunications.com/contact-us/.